148 related articles for article (PubMed ID: 26775700)
1. Survivin, a novel target of the Hedgehog/GLI signaling pathway in human tumor cells.
Vlčková K; Ondrušová L; Vachtenheim J; Réda J; Dundr P; Zadinová M; Žáková P; Poučková P
Cell Death Dis; 2016 Jan; 7(1):e2048. PubMed ID: 26775700
[TBL] [Abstract][Full Text] [Related]
2. Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas.
Ozretić P; Trnski D; Musani V; Maurac I; Kalafatić D; Orešković S; Levanat S; Sabol M
Int J Oncol; 2017 Dec; 51(6):1869-1877. PubMed ID: 29039491
[TBL] [Abstract][Full Text] [Related]
3. Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy.
Réda J; Vachtenheim J; Vlčková K; Horák P; Vachtenheim J; Ondrušová L
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201866
[TBL] [Abstract][Full Text] [Related]
4. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells.
Mazumdar T; Sandhu R; Qadan M; DeVecchio J; Magloire V; Agyeman A; Li B; Houghton JA
PLoS One; 2013; 8(9):e75253. PubMed ID: 24086482
[TBL] [Abstract][Full Text] [Related]
6. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
[TBL] [Abstract][Full Text] [Related]
7. Nek2A/SuFu feedback loop regulates Gli-mediated Hedgehog signaling pathway.
Zhou F; Huang D; Li Y; Hu G; Rao H; Lu Q; Luo S; Wang Y
Int J Oncol; 2017 Feb; 50(2):373-380. PubMed ID: 28035348
[TBL] [Abstract][Full Text] [Related]
8. Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding.
Agyeman A; Jha BK; Mazumdar T; Houghton JA
Oncotarget; 2014 Jun; 5(12):4492-503. PubMed ID: 24962990
[TBL] [Abstract][Full Text] [Related]
9. Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling.
Lipinski RJ; Gipp JJ; Zhang J; Doles JD; Bushman W
Exp Cell Res; 2006 Jul; 312(11):1925-38. PubMed ID: 16571352
[TBL] [Abstract][Full Text] [Related]
10. Gli2 expression and human bladder transitional carcinoma cell invasiveness.
Mechlin CW; Tanner MJ; Chen M; Buttyan R; Levin RM; Mian BM
J Urol; 2010 Jul; 184(1):344-51. PubMed ID: 20488474
[TBL] [Abstract][Full Text] [Related]
11. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis.
Hu MC; Mo R; Bhella S; Wilson CW; Chuang PT; Hui CC; Rosenblum ND
Development; 2006 Feb; 133(3):569-78. PubMed ID: 16396903
[TBL] [Abstract][Full Text] [Related]
12. The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells.
Horák P; Kreisingerová K; Réda J; Ondrušová L; Balko J; Vachtenheim J; Žáková P; Vachtenheim J
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36866769
[TBL] [Abstract][Full Text] [Related]
13. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
[TBL] [Abstract][Full Text] [Related]
14. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Hedgehog Signaling Pathway Abnormality on Chemothe-rapeutic Resistance of Multiple Myeloma].
Hu JS; Huang X; Huang YD; Lu YY; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):465-470. PubMed ID: 28446294
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype.
Sheng H; Goich S; Wang A; Grachtchouk M; Lowe L; Mo R; Lin K; de Sauvage FJ; Sasaki H; Hui CC; Dlugosz AA
Cancer Res; 2002 Sep; 62(18):5308-16. PubMed ID: 12235001
[TBL] [Abstract][Full Text] [Related]
17. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth.
Kawabata N; Ijiri K; Ishidou Y; Yamamoto T; Nagao H; Nagano S; Maeda S; Komiya S; Setoguchi T
Int J Oncol; 2011 Oct; 39(4):899-906. PubMed ID: 21674124
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma.
Tang L; Tan YX; Jiang BG; Pan YF; Li SX; Yang GZ; Wang M; Wang Q; Zhang J; Zhou WP; Dong LW; Wang HY
Clin Cancer Res; 2013 Apr; 19(8):2014-24. PubMed ID: 23493353
[TBL] [Abstract][Full Text] [Related]
20. FOXE1, a new transcriptional target of GLI2 is expressed in human epidermis and basal cell carcinoma.
Eichberger T; Regl G; Ikram MS; Neill GW; Philpott MP; Aberger F; Frischauf AM
J Invest Dermatol; 2004 May; 122(5):1180-7. PubMed ID: 15140221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
